ResearcherFujian Medical UniversityNo recent work listed

Hada Buhe

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5030869659. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 2 papers

Papers 2

IDO-1 inhibitor INCB24360 elicits distant metastasis of basal extruded cancer cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41401-022-01035-w ↗
Construction of a pancreatic cancer nerve invasion system using brain and pancreatic cancer organoids. Co-author DOI 10.1177/20417314221147113 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lixiang Ma · 2 shared papers, 2023 · strength 0.38
- Paper Construction of a pancreatic cancer nerve invasion system using brain and pancreatic cancer organoids. DOI 10.1177/20417314221147113 ↗
- Paper IDO-1 inhibitor INCB24360 elicits distant metastasis of basal extruded cancer cells in pancreatic ductal adenocarcinoma. DOI 10.1038/s41401-022-01035-w ↗
Chenyun Song · 2 shared papers, 2023 · strength 0.38
- Paper Construction of a pancreatic cancer nerve invasion system using brain and pancreatic cancer organoids. DOI 10.1177/20417314221147113 ↗
- Paper IDO-1 inhibitor INCB24360 elicits distant metastasis of basal extruded cancer cells in pancreatic ductal adenocarcinoma. DOI 10.1038/s41401-022-01035-w ↗
Hexige Saiyin · 2 shared papers, 2023 · strength 0.38
- Paper Construction of a pancreatic cancer nerve invasion system using brain and pancreatic cancer organoids. DOI 10.1177/20417314221147113 ↗
- Paper IDO-1 inhibitor INCB24360 elicits distant metastasis of basal extruded cancer cells in pancreatic ductal adenocarcinoma. DOI 10.1038/s41401-022-01035-w ↗
Xu Han · 1 shared paper, 2023 · strength 0.18
- Paper IDO-1 inhibitor INCB24360 elicits distant metastasis of basal extruded cancer cells in pancreatic ductal adenocarcinoma. DOI 10.1038/s41401-022-01035-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.